News
ENDECE to Present at the 22nd Annual International Partnering Conference BIO-Europe in Cologne, Germany
November 2, 2016
ENDECE will participate in BIO-Europe, the 22nd Annual International Partnering Conference, in Colog...Read More
ECTRIMS 2016
September 15, 2016
A small molecule therapy for MS patients appears to override inhibitors of oligodendrogenesis to ind...Read More
ENDECE to Present Data at the 2016 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress
September 14, 2016
ENDECE will present “A small molecule therapy for MS patients appears to override inhibitors of ol...Read More
ENDECE Receives Additional U.S. Patent Covering NDC-1308 for Inducing Remyelination
July 12, 2016
Patent Strengthens ENDECE’s Intellectual Property and Clinical Development Programs for Potential ...Read More
ENDECE Newsletter May 2016
June 1, 2016
NDC-1308 Timeline, Drug Approval Process. How close is NDC-1308 To The Clinic?...Read More
ENDECE to Present Data on NDC-1308, a Small Molecule with Remyelinating Activity for Treatment of Secondary Progressive Multiple Sclerosis
May 9, 2016
ENDECE will present “NDC-1308, a Small Molecule with Remyelinating Activity for Treatment of Secon...Read More